Furthermore, a study by Mutala et al. (2021) reported that tumor cells of most CRCs display a functional and activated caspase-1/IL-18 axis that can modulate the IFN-γ response elicited by the Th1/Tc1 response. Here, CASP1 is linked to neoplasm.